Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Dvorak
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital of the Muhc
Montreal, Quebec, Canada
- Starship Children'S Hospital
Grafton, Auckland, New Zealand
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Mattel Children'S Hospital Ucla
Los Angeles, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Norton Children'S Hospital
Louisville, Kentucky, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- the Childrens Mercy Hospital
Kansas City, Missouri, United States
- Cardinal Glennon Children'S Medical Center
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Columbia University/herbert Irving Cancer Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Montefiore Medical Center - Moses Campus
The Bronx, New York, United States
- New York Medical College
Valhalla, New York, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Rainbow Babies and Childrens Hospital
Cleveland, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oregon Health and Science University
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jun 2013
- Primary completion
- 31 Dec 2017
- Completion
- 31 Dec 2017
- Last update posted
- 5 Dec 2018
- Registered enrollment
- 30
- Registry id
- NCT01824693
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.